Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.2.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.450NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.130NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.444NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.344NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.103NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.485NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.119NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.276NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.111NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.336NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.400.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.537NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.548NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.24.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.492NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.540NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.487NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.118NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.513NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.338NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.284NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.498NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.184NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.187NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.342NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.500NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.511NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.428.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.506NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20641US
B.1.482NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.335NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.499.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.116NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.134NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.381NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used